Document Type
Article
Publication Date
8-19-2020
Abstract
Hamman-Rich syndrome is a rapidly progressive interstitial lung disease with acute respiratory distress syndrome physiology. It carries a grave prognosis and a high early mortality rate. It is often distinguished from other similar pulmonary pathologies based on the clinical course, laboratory findings, bronchoalveolar lavage testing, and pathology report. We detail a 77-year-old lady with no prior pulmonary disease, smoking history, or occupational and environmental exposures present to the emergency department found to be in acute hypoxic respiratory failure with impressive progressive radiographic findings. The presumptive diagnosis of Hamman-Rich syndrome was made based on a combination of factors after ruling out other similar clinical entities, especially in the setting of an ongoing COVID-19 pandemic.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Zhang, Qian; Raza, Ahmad; Chan, Vincent; Minalyan, Artem; and Madara, MD, John, "Hamman-Rich Syndrome: A Diagnosis of Exclusion in the COVID-19 Pandemic." (2020). Abington Jefferson Health Papers. Paper 41.
https://jdc.jefferson.edu/abingtonfp/41
PubMed ID
32963907
Language
English
Comments
This article is the author’s final published version in Cureus, Volume 12, Issue 8, August 2020, Article number e9866.
The published version is available at https://doi.org/10.7759/cureus.9866. Copyright © Zhang et al.